All Rapid Diagnostics articles
-
NewsTransforming HIV diagnosis: a low-cost, point-of-care detection solution
A team of researchers has developed an innovative handheld device for human immunodeficiency virus (HIV) detection that combines paper-based sample preparation with real-time isothermal amplification.
-
NewsBiosensing platform simultaneously detects vitamin C and SARS-CoV-2
A portable and sensitive biosensing device has been developed by engineering researchers to detect both SAR-CoV-2 and vitamin C simultaneously, to monitor and boost health for the general public.
-
NewsBlood test eases diagnosis of invasive mold disease
A newly developed blood test, as a non-invasive alternative, could be used to provide a rapid and safe diagnosis for invasive mold infections of the immunocompromised. It can also be applied for other infectious diseases, e.g. tuberculosis.
-
CareersHow frontline innovation from military labs can fight antimicrobial resistance worldwide
CEO at Presymptom Health, Dr. Iain Miller reveals how research in military laboratories - born out of battlefield demands - is now yielding innovative tech that allows for faster and more accurate detection of infections, even before symptoms appear.
-
NewsAsthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
A recent study suggests that patients with chronic rhinosinusitis, who had undergone endoscopic sinus surgery, have a higher chance of undergoing revision sinus surgery that removes nasal polyps if they have asthma and are using antibiotics.
-
NewsLancaster University spinout secures funding to advance healthcare diagnostics
Lancaster University spin out CCI Photonics has secured significant funding to develop its diagnostic technology, which aims to improve healthcare outcomes by using AI to detect infectious diseases and determine patients’ antibiotic susceptibilities in under 15 minutes.
-
NewsNew phage platform pinpoints viruses that can deliver a knockout blow for killer bacteria
An international group of microbial experts has launched a powerful and flexible free online genomic toolkit for more rapid development of phage therapy. They say it is capable of assessing if a phage is suitable for a targeted therapy in under 10 minutes.
-
NewsWe know what you ate: Detailed protein maps assess intestinal health
A new method has been designed to map the near-exact molecular details of the human and bacterial protein regulations within the host-gut microbiome interactions. These proteins could be used for medical and dietary intervention to maintain intestinal health.
-
FeaturesBridging the gap: mouse breath research to advance infectious disease diagnostics
The role of VOCs in health and disease is garnering increasing attention, particularly in their use as biomarkers for a wide range of medical conditions.
-
NewsTB or not TB? A new clinician decision support tool for tuberculosis
A risk assessing tool was recently developed to evaluate the likelihood of tuberculosis (TB) infections using previous patient data with or without TB. Such clinical decision support tool would allow safer and more efficient patient deisolation procedures and ensure smoother clinician workflows.
-
NewsCARB-X funds Rhode Island Hospital to assess feasibility of direct from blood detection of bacterial pneumonia
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award Rhode Island Hospital at Brown University Health US$1M to demonstrate proof-of-concept of a polymerase chain reaction (PCR) approach informed by RNA sequencing to detect bacterial pneumonia directly from whole blood.
-
NewsUltrasensitive test detects, serially monitors intact virus levels in patients with COVID-19
A highly sensitive approach, adapted from cancer vesicles detection, was discovered to be able to detect SARS-CoV-2 viral particles in fluid samples of patients with acute COVID-19 infections.
-
CareersThe true cost of science
Discover valuable insights from three companies in the microbiology field, and their experience of balancing innovation, investment, and sustainability to drive their success.
-
NewsPediatric investigation study examines the diagnostic potential of microbial cell-free DNA testing
A research study has found that plasma-based microbial cell-free DNA testing served as a safer and faster alternative to conventional microbiological diagnostic tests for pediatric ear, nose and throat (ENT) infections.
-
NewsScientists develop new 'twindemic' diagnostic system for rapid viral testing
A team of scientists has recently developed a novel TwinDemic Detection (TDD) system, designed for simultaneous detection of SARS-CoV and influenza A virus (IAV).
-
NewsCARB-X funds Melio to develop rapid diagnostic to detect neonatal sepsis
CARB-X will award biotechnology company Melio US$3.5M to develop and execute a technical feasibility workplan for its culture-free platform designed to identify blood stream infections including neonatal sepsis.
-
NewsBreakthrough infection test designed to tackle AMR on target for 2025 UK NHS availability after positive trial results
UK medtech company Presymptom Health has announced positive results from its clinical trial of diagnostic technology in the management of infection and sepsis in patients presenting to Emergency Departments with respiratory infection.
-
NewsNanorobot hand made of DNA grabs viruses for diagnostics and blocks cell entry
A tiny, four-fingered ‘hand’ folded from a single piece of DNA can pick up the virus that causes COVID-19 for highly sensitive rapid detection and can even block viral particles from entering cells to infect them.
-
NewsResearchers develop a simple lab-free test to detect bacteria in fluids from water to urine
A novel new test for bacteria in fluids makes it as easy as observing a colour change to confirm the presence of disease-causing pathogens, promising much easier diagnostic tests and greater food safety.
-
NewsGlobal research team develops advanced H5N1 detection kit to tackle avian flu
Researchers have developed an advanced diagnostic kit for detecting the highly pathogenic H5N1 Avian Influenza Virus (AIV). This development marks a significant breakthrough in avian influenza monitoring, reinforcing global efforts in pandemic preparedness.
